Summary Serial frozen sections from eleven patients with malignant breast tumours and five patients with benign disease were studied by indirect immunoperoxidase using a panel of mouse monoclonal antibodies to human leucocyte antigens. More infiltrating leucocytes were seen in tumour sections than those of benign conditions. A considerable proportion of the infiltrating cells were T cells, and more of these were of the suppressor/cytotoxic subset than the helper/inducer subset. The T cells were apparently not all activated as indicated by lower levels of staining with anti HLA-DR than anti-leucocyte antibody. Diffuse staining was sometimes seen with HLA-DR and T cell subset antibodies. Tumour cells did not stain or were only very weakly positive with anti HLA-A, B, C.
A variety of different techniques have been used to establish the immunological competence of the breast cancer patient. Among the experimental techniques which have been used to establish immunological competence are delayed hypersensitivity to skin test antigens (Stein et al., 1976) , lymphoproliferative responses (Dean et al., 1979; Jerrells et al., 1978) , numbers of leucocytes in peripheral blood (Keller et al., 1976) and the histological appearance of the local lymph node (Cutler et al., 1969; Heidenrich et al., 1979) .
The results of these studies have been inconclusive since there is both evidence for immunological hyporesponsiveness in patients with advanced disease (Lamb et al., 1962; Humphrey et al., 1980) and data to suggest that some patients make a response to their tumour (Black, 1973; Bleumink et al., 1974 and Nemoto et al., 1974) . None of these studies have, however, yielded definitive prognostic information.
Few authors have attempted to analyse inflammatory infiltrates at the site of tumours in detail as a prognostic indicator or as a means of assessing a specific anti-tumour response. Nevertheless it has been suggested that lymphocytic infiltration of the primary tumour indicates a favourable prognosis (Humphrey et al., 1980) and that the infiltrate consists predominantly of tumour directed cytotoxic lymphocytes (Schoorl et al., 1976; Lauder, 1977; Hayry & Totterman, 1978) .
With the development of monoclonal antibodies to cell surface and cytoplasmic components of the lymphoid and myeloid cell series, more precise identification of infiltrating leucocytes 
Collection of specimens
The specimens obtained at surgery were snap frozen in isopentane using a dry ice/acetone coolant. They were stored at -70°C or in liquid nitrogen. Serial sections 6 um thick were cut and air-dried and stored at -20°C or -50°C, prior to examination.
Staining
Indirect immunoperoxidase Sections were fixed in acetone at room temperature for 10 min and then washed for 1 min in Tris-buffered saline (TBS), following which they were incubated in the monoclonal first layer for 30 min at room temperature. The excess antibody was drained off and the sections washed for min in TBS. They were then incubated with a 1/50 dilution of horse radish peroxidase conjugated rabbit anti-mouse immunoglobulin. Following 30 min incubation and a 1 min wash in TBS, sections were incubated with diaminobenzidine at a concentration of 6 mg in 1Oml. Three ul H202 was added to this just before adding to the sections. After 7min incubation the sections were washed in 3 changes of TBS, and then for 1 h in tap water.
Counterstaining was for 12 sec in Mayer's haematoxylin. Sections were blued in tap water, dehydrated through a series of graded alcohols (50, 70, 90, 100% -2 changes, 5min each) and cleared in Xylene, 2 changes 5 min each. Permanent mounts were made in DPX. Antisera UCHTI (T28) is an IgGI mouse monoclonal antibody derived from an immunisation of Balb/c mice with human thymocytes followed by Sezary T cells. It identifies the T3 antigen present on mature T lymphocytes and some thymocytes (Beverley & Callard, 1981) .
DA2 is a monoclonal antibody of IgGI class with specific for a non-polymorphic determinant of HLA-DR (Brodsky et al., 1979) . It was a gift of Dr M. Crumpton.
Anti HLe-J (2D1) is an IgGl mouse monoclonal antibody derived from a mouse immunised with human peripheral blood mononuclear cells (PBL) and identifies a determinant present on human T cells, B cells, monocytes and granulocytes (Beverley, 1980) . 2AJ This is an IgGl mouse monoclonal antibody derived from mice immunised with human PBL (Beverley, 1980) . It identifies a human HLA-A, B, C non polymorphic determinant.
Leu 2a/UCHT4 Leu 2a (Becton Dickinson) is an
IgG mouse anti-human monoclonal antibody recognising the suppressor/cytotoxic T cell subset (Ledbetter et al., 1981) . UCHT4 cross inhibits with Leu 2a in binding assays and shows identical cell and tissue distribution patterns (unpublished data). These two antibodies gave similar results in this study.
Leu 3a (Becton Dickinson) is an IgGi mouse antihuman monoclonal antibody recognizing the helper/inducer T cell subset (Ledbetter et al., 1981) .
Anti mouse immunoglobulin Horse radish peroxidase conjugated rabbit anti mouse immunoglobulin antiserum was purchased from Dako and absorbed by passage through a sepharose 4B human immunoglobulin column.
Results
Results were quantitated using a 0-++++ scale, where + + + was the heaviest infiltrate seen Non malignant sections (Table 1) Similar results were seen in all cases of benign disease and "normal" controls (macroscopically normal tissue from mastectomy specimens). Labelling with the anti-HLA Class I antibody (2A1) was positive in all, but showed considerable differences in anatomical localisation. Leucocytes were invariably positive, but fibrous and epithelial tissue varied considerably in the extent of labelling from patient to patient. Some ducts were uniformly positive and some negative while others showed only a proportion of positive cells. Leucocytes were found scattered throughout ducts. In no case was the labelling uniformly positive for every cell type (Figure 1) .
The control results for HLe-1 indicate leucocyte infiltration in all cases, but this never exceeded a fairly modest level (+ +). Most of the staining occurred within duct walls and cellular areas. Labelling normally picked up scattered isolated cells as opposed to large clumps (Figure 2 ). Very little labelling occurred in fibrous areas.
Relatively few T cells as shown by UCHTI were seen in the benign and control sections, the score never exceeding +. Results suggest that these T cells are probably HLA-DR positive, since there was as much staining with DA2 as HLe-l and it exceeded that for UCHTI. T cells were almost exclusively confined to ducts and hyperplastic areas and were not found in fibrous material.
Labelling with Leu 2a was seen in areas which were UCHT1 positive, although it was difficult to Staining by HLe-l, UCHT1, Leu 2a and Leu 3a, was confined to cell membranes only. The anti MHC antibodies, 2A1 and DA2 showed both membrane and cytoplasmic staining.
Malignant tissue sections (Table II) The staining with 2A1 was again variable both in quantity and anatomic localisation. Leucocytes were invariably positive as in the non-malignant sections. Tumour cells were generally negative, or weakly positive (Figure 3) , particularly where confined to ducts where they are easier to identify. Fibrous areas stained variably in different patients.
Leucocyte infiltrates stained with HLe-I were found in all patients except Patient 5 in whom tumour had been replaced by reactive fibrosis in the sections examined and hence could not be regarded as a malignant area. In 5 of the patients, + + infiltrate or greater was seen (Patients: 1, 2, 3, 9, 1 1; Table II ). In the remainder at least + was seen (apart from Patient 5 already mentioned. Overall, this is considerably greater than that seen in non-malignant samples. In many of the patients, the infiltrates were mainly around the edge of the tumour mass, (Patients: 1, 6, 7, 10; Table II, Figure 4) and not infiltrating the malignant area, whereas in others stained cells were in juxtaposition with the tumour (Figure 5 ). In the cases where both malignant and "normal" material from the same breast was available (Patient 3, Figure 6 ) the staining was obviously as much HLe-1, whereas in the remainder of cases, it was slightly less (Patients 2, 4, 6, 10 (Figure 7) .
Leu 2a always stained a high proportion of those cells stained with UCHT1. In some cases (Patients 2, 3, 4, 9, 10, 11 ) the amount of labelling indicated that the majority of UCHT1 positive cells were also Leu 2a positive. In the remainder it appeared that a lesser proportion were positive. In contrast staining with Leu 3a was only + or greater in two patients (nos. 3, 9; Table II ). In the remainder only very few Leu 3a positive cells were seen (mainly scoring 0-. +). In 2 patients (nos. 9, 11; Table II) very diffuse labelling was seen in addition to the characteristic discrete membrane marking seen in the other patients. The overall level of labelling was slightly less than that seen for Leu 2a (Figures 8  and 9 ).
Discussion
The importance of infiltrating leucocytes as prognostic indicators in breast disease has been a matter of dispute. This immunohistological study was therefore carried out in an attempt to determine whether the more precise identification of leucocyte subsets which can be achieved with monoclonal antibodies would provide useful diagnostic or prognostic information. In addition, identification of cells present in tumours may provide some clues as to the nature of immune responses to tumours. We used as a positive control an antibody (2A1) against a non-polymorphic determinant of HLA-A, B, C but while this stained infiltrating leucocytes well, the staining of normal breast tissue was variable, some areas appearing to lack HLA completely. Malignant breast tumour cells at best stained weakly and in many cases appeared negative (Figure 3 ). While this may be partly a matter of the sensitivity of the immunoperoxidase method employed, others have made similar observations on tissue sections (Fleming et al., 1981) , and some breast derived cell lines show low levels of expression of HLA antigens (Travers et al., 1981) . Thus it is likely that both normal and malignant breast epithelial cells exhibit a bias toward low expression of HLA. Since at least cytotoxic T cells recognise target antigens in association with HLA-A, B, C antigens (McMichael, 1978) (Rowe et al., 1983) .
While leucocyte infiltration has been associated with a favourable prognosis (Lauder et al., 1977; Black et al., 1975) helper/inducers (Fox et al., 1982; Rowe et al., 1983) .
Our results raise a number of other questions. In the patients with the heaviest infiltrates (Patients 1, 7, 9; Table II) there was evidence of axillary node involvement which would normally be considered to worsen the prognosis but the numbers of patients examined in this study is too small to draw any firm conclusions. Similarly, although leucocytes are sometimes seen only surrounding tumour masses, and in other specimens within the tumour, we are as yet unable to determine whether these differences are important or trivial, perhaps resulting from sampling errors. In some patients diffuse labelling with the Leu 3a antibody was seen, the significance of this is obscure although we have occasionally noted a similar appearance in "normal" tonsils.
In conclusion this prelrminary study, while it raises intriguing questions as to the role of the infiltrating leucocytes in breast tumours, has not delineated immunohistological features which appear likely to provide more reliable prognostic information than can obtained by conventional histology. 
